SHERIDAN, WY, UNITED STATES, Oct. 19, 2022 /EINPresswire.com/ — According to IMARC Group’s latest report, titled Cervical Cancer Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunities and Forecasts 2022- 2027″. The global market size for cervical cancer diagnostics reached US$7.1 billion in 2021. Looking ahead, IMARC Group expects the market to reach $9.9 billion by 2027, which will show a growth rate (CAGR) of 5.57% over the period 2022-2027. Cervical cancer is a type of cancer that generally occurs in the cervix. The diagnosis of cervical cancer depends on a series of advanced laboratory tests, instruments, procedures, etc. to assess abnormal cells or strains of the human papillomavirus (HPV). They are usually performed by taking a sample of tissue obtained by conization, core biopsy, endocervical curettage, and the electric wire loop for a thorough examination of the cervix during colposcopy. After detection, tests are performed, including blood tests, chest X-rays, body computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), visual examination of the bladder and rectum, etc. to determine the disease stage.
We regularly track the direct impact of COVID-19 on the market as well as the indirect impact of related industries. These observations are integrated into the report.
Get a sample copy of this report: https://www.imarcgroup.com/cervical-cancer-diagnostics-market/requestsample
Global Cervical Cancer Diagnosis Market Trends:
The increasing number of individuals diagnosed with Sexually Transmitted Infections (STIs) such as Syphilis, Chlamydia, Gonorrhea, Acquired Immune Deficiency Syndrome (AIDS), etc. are developing risk of HPV infection mainly stimulating cervical muscle in the global cancer diagnostics market. Apart from that, the growing awareness of consumers for early diagnosis is fueling the adoption of home HPV test kits that provide fast and accurate test results, thus bolstering the market growth. In addition, the increasing demand for personalized treatment plans and the introduction of favorable reimbursement policies by government agencies are driving the global market. That being said, the ready availability of other treatment options including surgery, radiation therapy, chemotherapy, cone biopsy, immunotherapy, and trachelectomy acts as another important growth factor. In addition, the increasing focus on developing cost-effective and efficient testing products is expected to boost the cervical cancer diagnostics market in the forecast period.
Ask Analyst for Instant Discount and Download Full Report with TOC and Figure List: https://www.imarcgroup.com/cervical-cancer-diagnostics-market
Analysis and Segmentation of Global Cervical Cancer Diagnostics Market 2022-2027:
Competitive landscape with key players:
• Abbott Laboratories
• Arbor Vita Corporation
• Dickinson and Company
• Cooper Surgical Inc.
• Hoffmann-La Roche AG
• Guided Therapeutics Inc.
• Hologic Inc.
• Quest Diagnostics Incorporated
• Siemens Healthcare GmbH
Breakdown by test type:
• Pap test
• HPV test
• Cervical biopsies
Allocation by age groups:
• 20 to 35 years
• Over 35 years
Breakdown by region:
• North America (United States, Canada)
• Europe (Germany, France, UK, Italy, Spain, others)
• Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, others)
• Latin America (Brazil, Mexico, others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key highlights of the report:
• Market performance (2016-2021)
• Market Outlook (2022-2027)
• Porter’s Five Forces Analysis
• Market drivers and success factors
• SWOT analysis
• Value chain
• Comprehensive mapping of the competitive landscape
Note: If you require specific information that is not currently included in the scope of the report, we can provide it to you as part of the customization.
Other IMARC Group reports:
IMARC Group is a leading market research company providing management strategies and market research worldwide. We partner with clients across sectors and geographies to identify their most valuable opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products cover key market, scientific, economic and technological developments for executives in pharmaceutical, industrial and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food & beverage, travel & tourism, nanotechnology and advanced processing methods are at the forefront of the company’s expertise.
IMARC Services Private Limited
email us here